SG11201502104YA - Drug delivery systems and methods for treatment of bladder voiding dysfunction and other lower urinary tract disorders by using trospium - Google Patents
Drug delivery systems and methods for treatment of bladder voiding dysfunction and other lower urinary tract disorders by using trospiumInfo
- Publication number
- SG11201502104YA SG11201502104YA SG11201502104YA SG11201502104YA SG11201502104YA SG 11201502104Y A SG11201502104Y A SG 11201502104YA SG 11201502104Y A SG11201502104Y A SG 11201502104YA SG 11201502104Y A SG11201502104Y A SG 11201502104YA SG 11201502104Y A SG11201502104Y A SG 11201502104YA
- Authority
- SG
- Singapore
- Prior art keywords
- trospium
- treatment
- methods
- drug delivery
- delivery systems
- Prior art date
Links
- 208000026723 Urinary tract disease Diseases 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 230000004064 dysfunction Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- OYYDSUSKLWTMMQ-JKHIJQBDSA-N trospium Chemical compound [N+]12([C@@H]3CC[C@H]2C[C@H](C3)OC(=O)C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CCCC1 OYYDSUSKLWTMMQ-JKHIJQBDSA-N 0.000 title 1
- 229960001491 trospium Drugs 0.000 title 1
- 208000014001 urinary system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261702576P | 2012-09-18 | 2012-09-18 | |
PCT/US2013/060479 WO2014047221A1 (en) | 2012-09-18 | 2013-09-18 | Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502104YA true SG11201502104YA (en) | 2015-05-28 |
Family
ID=49301639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502104YA SG11201502104YA (en) | 2012-09-18 | 2013-09-18 | Drug delivery systems and methods for treatment of bladder voiding dysfunction and other lower urinary tract disorders by using trospium |
Country Status (13)
Country | Link |
---|---|
US (2) | US10500200B2 (pt) |
EP (1) | EP2897616A1 (pt) |
JP (2) | JP6600256B2 (pt) |
KR (1) | KR102141433B1 (pt) |
CN (2) | CN111450093A (pt) |
AU (1) | AU2013318146B2 (pt) |
BR (1) | BR112015005351A2 (pt) |
CA (1) | CA2883855C (pt) |
IL (1) | IL237498B (pt) |
MX (2) | MX2015003110A (pt) |
RU (1) | RU2670749C9 (pt) |
SG (1) | SG11201502104YA (pt) |
WO (1) | WO2014047221A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
AU2013308465B2 (en) | 2012-08-31 | 2018-05-17 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
RU2657591C2 (ru) | 2012-08-31 | 2018-06-14 | ТАРИС Биомедикал ЛЛК | Способ лечения рака мочевого пузыря оксалиплатином, соответствующее устройство его доставки, способ и устройство его введения |
MX2015003110A (es) * | 2012-09-18 | 2015-06-05 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
CN111214701A (zh) | 2014-08-19 | 2020-06-02 | 加利福尼亚大学董事会 | 用于局部药物递送的植入物及其使用方法 |
GB201506526D0 (en) | 2015-04-17 | 2015-06-03 | Uropharma Ltd And Synesis Llc | Medicinal composition |
CN106706832A (zh) * | 2015-08-06 | 2017-05-24 | 舒泰神(北京)生物制药股份有限公司 | 一种测定曲司氯铵含量的方法 |
CA3052148A1 (en) * | 2017-02-01 | 2018-08-09 | Taris Biomedical Llc | In vivo drug delivery devices and methods for drug delivery |
KR20210039403A (ko) * | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | 트로스피움을 사용한 과민성 방광의 치료 방법 |
WO2020222139A1 (en) * | 2019-04-30 | 2020-11-05 | Trigone Pharma Ltd. | Formulations and methods for drug instillation into the bladder and treatment of bladder ailments |
US11338119B2 (en) | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11173291B2 (en) | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
KR102596697B1 (ko) | 2021-05-20 | 2023-11-01 | 김정우 | 바위솔 추출물을 유효성분으로 포함하는 화장품 조성물 및 그 제조 방법 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59600683D1 (de) * | 1996-11-27 | 1998-11-19 | Pfleger R Chem Fab | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten |
EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
US20060058777A1 (en) * | 2002-12-11 | 2006-03-16 | Pia Norup Nielsen | Urinary catheter device with a pharmaceutically active composition |
CA2513188A1 (en) | 2003-01-16 | 2004-08-05 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
ES2322148T3 (es) | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
WO2006101954A2 (en) * | 2005-03-17 | 2006-09-28 | Indevus Pharmaceuticals, Inc. | Interstitial cystitis treatment |
US7390816B2 (en) | 2005-06-21 | 2008-06-24 | Bridge Pharma, Inc. | Methods for treating urinary incontinence in patients suffering from memory disorders |
CA2618349C (en) | 2005-08-11 | 2016-05-31 | Massachusetts Institute Of Technology | Intravesical drug delivery device and method |
EP1967202A1 (en) | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
CN101896221B (zh) | 2007-12-11 | 2013-06-05 | 麻省理工学院 | 用于治疗膀胱和其它体囊或体腔的可植入式药物递送设备和方法 |
CN102176931B (zh) | 2008-08-09 | 2015-03-04 | 麻省理工学院 | 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法 |
CN102470237A (zh) | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | 用于可植入药物递送装置的固体药物片剂 |
US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
RS61980B1 (sr) | 2009-12-17 | 2021-07-30 | Taris Biomedical Llc | Implantabilni uređaj sa intravezikalnom tolerancijom |
US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
US8690840B2 (en) | 2010-10-06 | 2014-04-08 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル,インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
WO2012106714A1 (en) * | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
MX2015003110A (es) * | 2012-09-18 | 2015-06-05 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
AU2014232801B2 (en) | 2013-03-15 | 2019-01-17 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
-
2013
- 2013-09-18 MX MX2015003110A patent/MX2015003110A/es unknown
- 2013-09-18 CN CN202010161062.6A patent/CN111450093A/zh active Pending
- 2013-09-18 JP JP2015532177A patent/JP6600256B2/ja active Active
- 2013-09-18 CN CN201380046758.2A patent/CN104684556A/zh active Pending
- 2013-09-18 KR KR1020157008403A patent/KR102141433B1/ko active IP Right Grant
- 2013-09-18 SG SG11201502104YA patent/SG11201502104YA/en unknown
- 2013-09-18 RU RU2015112196A patent/RU2670749C9/ru active
- 2013-09-18 WO PCT/US2013/060479 patent/WO2014047221A1/en active Application Filing
- 2013-09-18 BR BR112015005351A patent/BR112015005351A2/pt not_active Application Discontinuation
- 2013-09-18 CA CA2883855A patent/CA2883855C/en active Active
- 2013-09-18 EP EP13771696.5A patent/EP2897616A1/en active Pending
- 2013-09-18 AU AU2013318146A patent/AU2013318146B2/en active Active
-
2015
- 2015-03-02 IL IL237498A patent/IL237498B/en active IP Right Grant
- 2015-03-11 MX MX2020002465A patent/MX2020002465A/es unknown
- 2015-03-16 US US14/658,699 patent/US10500200B2/en active Active
-
2018
- 2018-02-02 JP JP2018017300A patent/JP2018080208A/ja active Pending
-
2019
- 2019-12-06 US US16/706,009 patent/US11850244B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2014047221A1 (en) | 2014-03-27 |
KR102141433B1 (ko) | 2020-08-05 |
WO2014047221A9 (en) | 2015-05-21 |
RU2670749C2 (ru) | 2018-10-25 |
KR20150058271A (ko) | 2015-05-28 |
CN104684556A (zh) | 2015-06-03 |
US20200108057A1 (en) | 2020-04-09 |
US11850244B2 (en) | 2023-12-26 |
AU2013318146A1 (en) | 2015-03-19 |
CA2883855C (en) | 2020-09-15 |
BR112015005351A2 (pt) | 2017-07-04 |
JP6600256B2 (ja) | 2019-10-30 |
JP2018080208A (ja) | 2018-05-24 |
JP2015529688A (ja) | 2015-10-08 |
US10500200B2 (en) | 2019-12-10 |
US20150182516A1 (en) | 2015-07-02 |
RU2015112196A (ru) | 2016-11-10 |
AU2013318146B2 (en) | 2018-05-10 |
MX2020002465A (es) | 2020-07-13 |
IL237498B (en) | 2018-01-31 |
EP2897616A1 (en) | 2015-07-29 |
CN111450093A (zh) | 2020-07-28 |
IL237498A0 (en) | 2015-04-30 |
CA2883855A1 (en) | 2014-03-27 |
MX2015003110A (es) | 2015-06-05 |
RU2670749C9 (ru) | 2018-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237498A0 (en) | Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium | |
EP2785275A4 (en) | TREATMENT OF HARNINE CONTINENCE | |
HK1198297A1 (en) | Compositions, uses and methods for treatment of metabolic disorders and diseases | |
EP2675402A4 (en) | BLOOD FLOW INTERFERENCE DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DEFECTS | |
EP2731658A4 (en) | DEVICE FOR DISTRIBUTING ANTIMICROBIAL AGENT IN TRANSDERMAL CATHETER | |
EP2704630A4 (en) | SYSTEM AND METHOD FOR TRACKING BRAIN STATES DURING THE ADMINISTRATION OF AN ANESTHETIC SYSTEM | |
EP2552357A4 (en) | MEDICAL DEVICE FOR THE TREATMENT OF HARNINE INCONTINENCE IN WOMEN | |
HK1202313A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
EP2782631A4 (en) | IMPLANTABLE APPARATUS FOR USE IN THE ADMINISTRATION OF A SOLID-LIQUID MEDICAMENT, ASSOCIATED FORMULATIONS AND METHODS OF USE | |
AU339607S (en) | Medical device for treatment of sleep disorders | |
IL229474A0 (en) | Cannabinoids for use in the treatment of neuropathic pain | |
IL237300A0 (en) | Drug delivery systems and methods for treating prostate gland diseases containing gemcitabine | |
HK1197276A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
HK1208830A1 (en) | Drug delivery device for the treatment of patients with respiratory diseases | |
IL227312A0 (en) | Lidocaine administration regimen for long-term treatment of bladder pain and voiding irritation | |
IL237281B (en) | Drug delivery systems and methods for treating bladder cancer comprising oxaliplatin | |
EP2678068A4 (en) | ACTIVE EXTRACTING BASIN TREATMENT SYSTEM AND METHOD | |
ZA201403767B (en) | Implantable drug delivery compositions and methods of treatment | |
GB2496688B (en) | Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases | |
ZA201502288B (en) | Ciclesonide for treatment of airway disease in horses | |
EP2763716A4 (en) | SOLID MEDICATION ADMINISTRATION APPARATUS, FORMULATIONS AND METHODS OF USE | |
EP2726079A4 (en) | METHOD OF ADMINISTRATION AND TREATMENT | |
EP2790637A4 (en) | VAGINAL DRUG DELIVERY DEVICES AND METHODS OF MANUFACTURING THE SAME | |
EP2673372A4 (en) | METHODS OF PROGNOSIS AND DELIVERY OF TREATMENT FOR INFLAMMATORY DISORDERS | |
HK1210209A1 (en) | Treatment of diseases of endothelial dysfunction and inflammation |